sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Updated 10/6/2026, 8:11 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | Sale | $1,905,768 | MPM BIOVENTURES 2018, L.P. 10% owner and 2 others | 259,837 sh | at $7.33 | Filed Sep 9, 7:24 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $1,905,768 | MPM BioVentures 2014, L.P. 10% owner and 9 others | 259,837 sh | at $7.33 | Filed Sep 9, 7:23 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $617,379 | MPM BIOVENTURES 2018, L.P. 10% owner and 2 others | 86,482 sh | at $7.14 | Filed Sep 3, 7:21 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $617,379 | MPM BioVentures 2014, L.P. 10% owner and 9 others | 86,482 sh | at $7.14 | Filed Sep 3, 7:21 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $615,777 | MPM BIOVENTURES 2018, L.P. 10% owner and 2 others | 86,914 sh | at $7.08 | Filed Aug 31, 6:26 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $615,777 | MPM BioVentures 2014, L.P. 10% owner and 9 others | 86,914 sh | at $7.08 | Filed Aug 31, 6:25 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $461,546 | MPM BioVentures 2014, L.P. 10% owner and 9 others | 62,714 sh | at $7.36 | Filed Aug 26, 9:28 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $461,546 | MPM BIOVENTURES 2018, L.P. 10% owner and 2 others | 62,714 sh | at $7.36 | Filed Aug 26, 9:27 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $1,078,937 | PARMAR KUSH Director | 155,255 sh | at $6.95 | Filed Aug 10, 7:54 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $431,829 | 5AM Ventures V, L.P. 10% owner and 5 others | 62,811 sh | at $6.88 | Filed Aug 10, 7:52 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $807,027 | 5AM Ventures V, L.P. 10% owner and 5 others | 116,474 sh | at $6.93 | Filed Aug 3, 5:32 PM ET | Filing | |
| TRDA Entrada Therapeutics, Inc. | Sale | $807,027 | PARMAR KUSH Director, 10% owner | 116,474 sh | at $6.93 | Filed Aug 3, 5:26 PM ET | Filing |